SI-BONE, Inc.
NASDAQ:SIBNMedical - Devices
+$0.53 today
- Market cap
- $1.06B
- Beta
- 0.70
- P/E (TTM)
- -41.4
- EPS (TTM)
- -$0.38
Volume 1.12M
Average 0.68M
SIBN Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
SI-BONE, Inc.NASDAQ: SIBN
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables growth accelerates
Q1 FY2026 accounts payables of $2.1M rose 120.4% year over year, ahead of the -239.6% change in trailing-twelve-month accounts payables.
Context
- Accounts payables amounted to 0.9% of revenue in FY2025, down 0.2 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +120.4% holds above the trailing-twelve-month pace of -239.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (1.76M) USD
- Year-over-year change
- -194.7%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.76M) | -194.7% |
| FY2024 | 2024-12-31 | 1.86M | +266.5% |
| FY2023 | 2023-12-31 | (1.12M) | -144.2% |
| FY2022 | 2022-12-31 | 2.53M | +575.4% |
| FY2021 | 2021-12-31 | (532K) | — |
Accounts Payables vs competitors
How SIBN compares with its peers on the latest reported figures
- SIBN's LTM Mar 2026 accounts payables of $617K is the 5th largest of the 6 companies compared; the peer median is $8.05M.
- Its year-over-year change of -239.6% is the lowest of 5, against a peer median of +177.2%.
- Accounts payables amounts to 0.3% of revenue for SIBN, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $236M | +84.4% | -31.3% | 0.9% | |
| LTM Jun 2026 | $17.96M | +790.5% | -16.2% | 0.6% | |
| LTM Mar 2026 | $8.05M | +243.6% | — | 0.6% | |
| LTM Mar 2026 | $963K | +110.7% | — | 0.1% | |
| LTM Mar 2026 | $617K | -239.6% | — | 0.3% | |
| FY2025 | $0 | — | — | 0.0% | |
| Peer median (excluding SIBN) | $8.05M | +177.2% | -23.7% | 0.6% | |
Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (56.57M) | (61.26M) | (43.34M) | (30.91M) | (18.9M) |
| Depreciation & Amortization | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M |
| Deferred Income Tax | 3.56M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 16.87M | 23.06M | 24.06M | 25.87M | 25.52M |
| Change in Working Capital | (5.76M) | (7.64M) | (4.83M) | (10.12M) | (14.33M) |
| Accounts Receivables | (569K) | (6.48M) | (2.12M) | (5.84M) | (3.03M) |
| Inventory | (5.78M) | (5.71M) | (4.72M) | (8.05M) | (8.68M) |
| Accounts Payables | (532K) | 2.53M | (1.12M) | 1.86M | (1.76M) |
| Other Working Capital | 1.13M | 2.02M | 3.13M | 1.91M | (851K) |
| Other Non-Cash Items | 288K | 730K | (29K) | (1.64M) | 4.31M |
| Operating Cash Flow | (39.53M) | (41.66M) | (18.71M) | (12.43M) | (675K) |
| Capital Expenditures | (6.39M) | (9.51M) | (7.8M) | (10.5M) | (8.41M) |
| Acquisitions (Net) | (57.97M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (102.02M) | (119.51M) | (189.5M) | (205.38M) | (192.53M) |
| Sales of Investments | 159.99M | 126.2M | 137.5M | 228.5M | 205.1M |
| Other Investing Activities | 57.97M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 51.58M | (2.82M) | (59.8M) | 12.62M | 4.16M |
| Debt Repayment | (6.62M) | 0 | 725K | (46K) | 0 |
| Common Stock Issued | 4.91M | 2.2M | 83.67M | 2.72M | 3.38M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 6.54M | (720K) | 0 |
| Financing Cash Flow | (1.71M) | 2.2M | 90.93M | 1.96M | 3.38M |
| Effect of Forex Changes | (498K) | (429K) | 132K | (479K) | 431K |
| Net Change in Cash | 9.84M | (42.7M) | 12.55M | 1.68M | 7.29M |
| Free Cash Flow | (45.92M) | (51.16M) | (26.51M) | (22.92M) | (9.09M) |
SI-BONE, Inc.
NASDAQ:SIBN
Intrinsic Alpha fair value
Locked
Current Price
$23.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.